Reuters logo
BRIEF-Fennec Pharmaceuticals reports Q2 ‍loss per share $0.11​
August 11, 2017 / 10:06 AM / 3 months ago

BRIEF-Fennec Pharmaceuticals reports Q2 ‍loss per share $0.11​

Aug 11 (Reuters) - Fennec Pharmaceuticals Inc

* Fennec provides corporate update and announces second quarter 2017 results

* Qtrly ‍loss per share $0.11​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below